CIK 0001506251 · Non-accelerated filer<br>Smaller reporting company
Citius Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CTXR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273425913
- Phone
- (908) 967-6676
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- Trail One, Inc., TrailOne, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-10 | Holuka Eugene Myron Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2023-10-10 | Dutia Suren G Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2023-10-10 | Bartushak Jaime Chief Financial Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +300,000 | 300,000 | ||
| 2023-10-10 | MCGRATH DENNIS M Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2023-10-10 | Mazur Leonard L Chief Executive Officer | Grant or award · Option to Purchase Common Stock | +550,000 | 550,000 | ||
| 2023-02-07 | MCGRATH DENNIS M Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2022-10-04 | Kane William Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2022-10-04 | Dutia Suren G Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2022-10-04 | HOLUBIAK MYRON Z Vice Chairman | Grant or award · Options to Purchase Common Stock | +400,000 | 400,000 | ||
| 2022-10-04 | Mazur Leonard L Executive Chairman | Grant or award · Option to Purchase Common Stock | +550,000 | 550,000 | ||
| 2022-10-04 | Bartushak Jaime Chief Financial Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +300,000 | 300,000 | ||
| 2022-10-04 | SAFIR HOWARD Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2022-10-04 | Holuka Eugene Myron Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2022-10-04 | Webb Carol Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 | ||
| 2022-10-04 | Czuczman Myron Chief Medical Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +300,000 | 300,000 | ||
| 2021-10-11 | HOLUBIAK MYRON Z President and CEO | Grant or award · Options to Purchase Common Stock | +650,000 | 650,000 | ||
| 2021-10-11 | HOLUBIAK MYRON Z President and CEO | Grant or award · Options to Purchase Common Stock | +15,000 | 15,000 | ||
| 2021-10-11 | Mazur Leonard L Executive Chairman | Grant or award · Option to Purchase Common Stock | +650,000 | 650,000 | ||
| 2021-10-11 | Bartushak Jaime Chief Financial Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +300,000 | 300,000 | ||
| 2021-10-11 | Dutia Suren G Director | Grant or award · Options to Purchase Common Stock | +75,000 | 75,000 |
Page 3 of 8 · 156 trades